Canada's Israel header image 2
Celebrating all that is similar and unique about our two amazing countries.

Israel and Canada Collaborate on Diagnosing Cancer and Diabetes

May 26th, 2009 · No Comments

By Karin Kloosterman

A couple of weeks ago I got an email from the diagnostics innovator Micromedic, based in Israel. The company has developed early detection kits for several varieties of cancer, and its kits can also play a role in early diagnosis of diabetes.

They have signed a memorandum of understanding to work with the Canadian firm Axela which will help Micromedic Technologies in marketing its kits for the research market.

Catching a disease or disorder early enough, can make all the difference in the world in seeing a successful outcome, so I can imagine a great number of Canadians as well as people all over the world will benefit from this technology and partnership.

Based on the research of one of Micromedic’s subsidiaries, the kits developed in Israel will be assimilated into Axela’s technology platform.

Micromedic, traded on the Tel Aviv Stock Exchange, will give Axela a license for marketing, distribution and sales of the kits for the research market in the United States and Canada.

Axela has developed equipment for real-time diagnostic tests and currently sells its products to leading institutes in the research market.

david-solomon-micromedic

David Solomon, CEO of Micromedic, called it “a milestone” for his company, as it’s the first agreement in marketing and commercialization for one of his companys’ technologies. There are six startups under the Micromedic umbrella.

The announcement was made on April 23, and according to the MOU, both companies will collaborate in the field of marketing and commercialization of biomarkers for the research market based on Micromedic’s products.

A definitive agreement will be signed in about 4 months, at which point we’ll probably get more details on what cancers Micromedics will help diagnose. I’d previously written about their work in colon cancer (screening with a blood test), and in developing a genetic test for the pre-disposition of bone rot. This nasty condition is caused in about 1% of all Canadian women who take drugs from the bisphosphonate family to reduce the effects of osteoporosis.

If you haven’t heard yet about the amazing things Israeli biotech entrepreneurs are doing to make your life just a little bit better – and healthier – stay tuned in this space for much more news like this.

Related posts:

  1. Prostate cancer sees the light of day
  2. Screening for Fetal Defects in Canada Vs Israel
  3. The Dad of DNA Methylation in Vancouver

Tags: Health & Science

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

You must log in to post a comment.